Shanafelt
Armen B. Shanafelt, Carmel, IN US
Patent application number | Description | Published |
---|---|---|
20090148403 | Interleukin-9 Antagonist Muteins and Their Pharmacological Methods of Use - This invention relates to IL-9 muteins that inhibit the activity of wild-type IL-9, multimers and Fc-fusion constructs of IL-9 proteins, and an efficient method to purify IL-9 proteins produced by eukaryotic cells. Related formulations, dosages and methods of administration thereof for therapeutic purposes are also provided. More particularly, these IL-9 muteins, compositions, and methods provide a treatment option for individuals afflicted with conditions where inhibiting IL-9 mediated immune responses would be beneficial, such as allergy, asthma, chronic obstructive pulmonary disease (emphysema and chronic bronchitis), pulmonary and gastro-intestinal mucus hyperplasia, inflammation, immunological disorders, leukemia, and lymphoma. | 06-11-2009 |
Colin Shanafelt, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20120297282 | Assessment document generation system and method - The present invention is an assessment document generation method and system whereby users generate assessment feedback documents by selecting appropriate indicator fields. Each indicator field and its accompanying indicator field label correspond to blocks of pre-written and fully editable text. After users move through the tabbed interface and select appropriate indicator fields, the software compiles the corresponding pre-written blocks of text into a final assessment document that can be stored, viewed, printed, transmitted electronically, and/or exported to a computer readable storage medium from within the software interface. The software is an assessment tool whereby users can quickly evaluate the work, products, and/or performances of others by selecting indicator fields to create a detailed, targeted, and comprehensive assessment feedback document. | 11-22-2012 |
Robert E. Shanafelt, Los Altos, CA US
Patent application number | Description | Published |
---|---|---|
20100302091 | WIDEBAND INTERFERENCE CANCELLATION USING DSP ALGORITHMS - A method and system is provided for detecting and characterizing pulsed threat radar emitters through heavy in-band interference. System includes an advanced digital signal processing method provides spatial and temporal interference cancellation, super-resolution direction-finding, and high resolution spectrum analysis techniques. The system receives the digitized output of a discriminator bank and produces highly accurate threat pulse radio frequency estimates. The invention further provides a two-channel configuration for a DF subsystem, to perform adjacent-beam direction-finding through severe interference environments. The invention provides increased sensitivity, increased frequency accuracy, and up to 40 dB of increased interference look-through capability in ES system but remains transparent to ES system functioning and to ES system operators. | 12-02-2010 |
Tait D. Shanafelt, Rochester, MN US
Patent application number | Description | Published |
---|---|---|
20120190638 | METHODS OF TREATING HEMATOLOGIC CANCERS - This disclosure relates to the treatment of hematologic cancers, for example, cancers of the blood, by methods that include administration of EGCG and at least one of a purine nucleoside analog and an alkylating agent. In particular, methods of treating chronic lymphocytic leukemia (CLL) and acute lymphocytic leukemia (ALL) are described. | 07-26-2012 |
20140274937 | METHODS OF TREATING HEMATOLOGIC CANCERS - This disclosure relates to the treatment of hematologic cancers, for example, cancers of the blood, by methods that include administration of EGCG and at least one of a purine nucleoside analog and an alkylating agent. In particular, methods of treating chronic lymphocytic leukemia (CLL) and acute lymphocytic leukemia (ALL) are described. | 09-18-2014 |